- Home
- CLLS vs EPSN Comparison
CLLS vs EPSN Comparison
Compare CLLS & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- EPSN
- Stock Information
- Founded
- CLLS 1999
- EPSN 2005
- Country
- CLLS France
- EPSN Canada
- Employees
- CLLS N/A
- EPSN N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- EPSN Oil & Gas Production
- Sector
- CLLS Health Care
- EPSN Energy
- Exchange
- CLLS Nasdaq
- EPSN Nasdaq
- Market Cap
- CLLS 144.4M
- EPSN 155.9M
- IPO Year
- CLLS 2007
- EPSN N/A
- Fundamental
- Price
- CLLS $1.49
- EPSN $7.21
- Analyst Decision
- CLLS Buy
- EPSN Strong Buy
- Analyst Count
- CLLS 3
- EPSN 1
- Target Price
- CLLS $6.67
- EPSN $7.00
- AVG Volume (30 Days)
- CLLS 46.6K
- EPSN 69.2K
- Earning Date
- CLLS 05-12-2025
- EPSN 05-14-2025
- Dividend Yield
- CLLS N/A
- EPSN 3.46%
- EPS Growth
- CLLS N/A
- EPSN N/A
- EPS
- CLLS N/A
- EPSN 0.20
- Revenue
- CLLS $54,747,000.00
- EPSN $39,699,172.00
- Revenue This Year
- CLLS $48.52
- EPSN $41.35
- Revenue Next Year
- CLLS $5.17
- EPSN N/A
- P/E Ratio
- CLLS N/A
- EPSN $35.32
- Revenue Growth
- CLLS 351.26
- EPSN 35.21
- 52 Week Low
- CLLS $1.10
- EPSN $4.95
- 52 Week High
- CLLS $2.78
- EPSN $7.35
- Technical
- Relative Strength Index (RSI)
- CLLS 51.15
- EPSN 57.23
- Support Level
- CLLS $1.46
- EPSN $6.91
- Resistance Level
- CLLS $1.60
- EPSN $7.35
- Average True Range (ATR)
- CLLS 0.08
- EPSN 0.25
- MACD
- CLLS -0.01
- EPSN 0.02
- Stochastic Oscillator
- CLLS 52.17
- EPSN 79.10
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About EPSN Epsilon Energy Ltd. Common Share
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.